Skip to content

Drug interactions

Buprenorphine subdermal implant + Rasagiline

Severity: Major

Buprenorphine subdermal implant and Rasagiline: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Opioids with serotonergic activity, including buprenorphine, can contribute to serotonin syndrome when combined with MAO inhibitors. Opioids also carry a risk of CNS and respiratory depression in this context.

What this interaction means in plain words

Buprenorphine subdermal implant and Rasagiline can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

Additive serotonergic effects of MAO inhibition and buprenorphine.

What to do

Avoid the combination if possible, otherwise monitor closely for serotonin toxicity, especially at initiation and dose changes. Remove the implant and treat if serotonin syndrome is suspected.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Rasagiline, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buprenorphine subdermal implant with Rasagiline?

MediHelp rates the interaction as major. Buprenorphine subdermal implant and Rasagiline can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Opioids with serotonergic activity, including buprenorphine, can contribute to serotonin syndrome when combined with MAO inhibitors. Opioids also carry a risk of CNS and respiratory depression in this context.

How serious is the interaction between Buprenorphine subdermal implant and Rasagiline?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible, otherwise monitor closely for serotonin toxicity, especially at initiation and dose changes. Remove the implant and treat if serotonin syndrome is suspected.

What other medicines interact with Rasagiline?

MediHelp also lists interactions of Rasagiline with, for example, Atomoxetine, Brimonidine, Bupropion-naltrexone. The full list is on the Rasagiline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in